Down-regulation of miR-214 reverses erlotinib resistance in non-small-cell lung cancer through up-regulating LHX6 expressionJinrong Liao(Fujian Medical University), Ying Su(Fujian Medical University)Scientific ReportsApril 4, 201710.1038/s41598-017-00901-6Cited by 60SaveCiteExport RISWatch citationsRelated PapersComparison of CRB-65 and quick sepsis-related organ failure assessment for predicting the need for intensive respiratory or vasopressor support in patients with COVID-19|Journal of Infection|2020|47